Cargando…
Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum
Cryptosporidium parvum is a highly prevalent zoonotic and anthroponotic protozoan parasite that causes a diarrheal syndrome in children and neonatal livestock, culminating in growth retardation and mortalities. Despite the high prevalence of C. parvum, there are no fully effective and safe drugs for...
Autores principales: | Li, Kun, Nader, Sara M., Zhang, Xuejin, Ray, Benjamin C., Kim, Chi Yong, Das, Aditi, Witola, William H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687188/ https://www.ncbi.nlm.nih.gov/pubmed/31356619 http://dx.doi.org/10.1371/journal.ppat.1007953 |
Ejemplares similares
-
Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity
por: Zhang, Xuejin, et al.
Publicado: (2018) -
Targeted gene knockdown validates the essential role of lactate dehydrogenase in Cryptosporidium parvum
por: Witola, William H., et al.
Publicado: (2017) -
Cryptosporidium parvum Pyruvate Kinase Inhibitors With in vivo Anti-cryptosporidial Efficacy
por: Khan, Shahbaz M., et al.
Publicado: (2022) -
Combination of inhibitors for two glycolytic enzymes portrays high synergistic efficacy against Cryptosporidium parvum
por: Khan, Shahbaz M., et al.
Publicado: (2023) -
The effect of halofuginone lactate on experimental Cryptosporidium parvum infections in calves
por: Naciri, Muriel, et al.
Publicado: (1993)